Overview

Study for Naltrexone on the Abuse Potential of Methylphenidate

Status:
Completed
Trial end date:
2018-06-20
Target enrollment:
Participant gender:
Summary
The current abuse liability study aims to assess the potential for co-administration of naltrexone (NTX) to reduce the abuse potential of methylphenidate (MPH).
Phase:
Phase 1
Details
Lead Sponsor:
Avekshan LLC
Treatments:
Methylphenidate
Naltrexone